Thank you for the opportunity to provide comments on the draft Sexually Transmitted Infections National Strategic Plan 2021-2025 (STI Plan). The HIV+Hepatitis Policy Institute is a leading HIV…
Comments on NAIC draft pharmacy benefit manager model law
Please find the attached comments by the HIV+HEP Policy Institute on the draft NAIC Pharmacy Benefits Manager (PBM) Model Law. The HIV+HEP Policy Institute is a leading HIV and hepatitis policy…
Comments on Medicaid rebate rule
The HIV+Hepatitis Policy Institute, a national, non-profit organization whose mission is to promote quality and affordable healthcare for people living with or at risk of HIV, hepatitis, and other serious…
Testimony for the Record Senate Labor HHS Appropriations Subcommittee (FY 2021)
On behalf of the HIV+Hepatitis Policy Institute, we respectfully submit this testimony in support of increased funding for domestic HIV and hepatitis programs in the FY 2021 Labor, HHS spending bill…
HIV+Hepatitis Policy Institute outlines FY2021 appropriations priorities
The HIV+Hepatitis Policy Institute appreciates the work the Senate has been doing over the last several months responding to the COVID-19 pandemic. We thank you for your continued attention to this crisis, particularly as it affects our nation’s public health infrastructure. We are very appreciative…